145 related articles for article (PubMed ID: 6424440)
1. Clinical pharmacology of glipizide.
Melander A; Wåhlin-Boll E
Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
[TBL] [Abstract][Full Text] [Related]
2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of sulfonylureas.
Melander A
Metabolism; 1987 Feb; 36(2 Suppl 1):12-6. PubMed ID: 3543616
[TBL] [Abstract][Full Text] [Related]
4. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of sulfonylureas: a brief review.
Melander A; Wåhlin-Boll E
Ann Clin Res; 1983; 15 Suppl 37():12-5. PubMed ID: 6679185
[TBL] [Abstract][Full Text] [Related]
6. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Lebovitz HE
Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
[TBL] [Abstract][Full Text] [Related]
7. Oral sulfonylureas for the treatment of type II diabetes: an update.
Shank WA; Morrison AD
South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
[TBL] [Abstract][Full Text] [Related]
8. The second generation sulfonylureas: glipizide and glyburide.
Baker DE; Campbell RK
Diabetes Educ; 1985; 11(3):29-36. PubMed ID: 3935402
[No Abstract] [Full Text] [Related]
9. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
Lev JD; Zeidler A; Kumar D
Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of sulfonylureas.
Skillman TG; Feldman JM
Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
[TBL] [Abstract][Full Text] [Related]
11. Kinetics-effect relations of glipizide and other sulfonylureas.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Endocrinol Suppl (Copenh); 1980; 239():3-5. PubMed ID: 6776762
[TBL] [Abstract][Full Text] [Related]
12. Glipizide and glyburide.
Kure J
N C Med J; 1986 Mar; 47(3):149-53. PubMed ID: 3083269
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
Balant L; Fabre J; Zahnd GR
Eur J Clin Pharmacol; 1975; 8(1):63-9. PubMed ID: 823030
[TBL] [Abstract][Full Text] [Related]
15. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview.
Melander A
Diabetes; 2004 Dec; 53 Suppl 3():S151-5. PubMed ID: 15561903
[TBL] [Abstract][Full Text] [Related]
16. Mortality risk among sulfonylureas: a systematic review and network meta-analysis.
Simpson SH; Lee J; Choi S; Vandermeer B; Abdelmoneim AS; Featherstone TR
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):43-51. PubMed ID: 25466239
[TBL] [Abstract][Full Text] [Related]
17. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic equivalence of once- and thrice-daily glipizide.
Wåhlin-Boll E; Groop L; Karhumaa S; Groop PH; Tötterman KJ; Melander A
Eur J Clin Pharmacol; 1986; 31(1):95-9. PubMed ID: 3536529
[TBL] [Abstract][Full Text] [Related]
19. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
Kilo C
Clin Ther; 1988; 10(3):294-302. PubMed ID: 3152586
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics.
Wåhlin-Boll E; Almér LO; Melander A
Clin Pharmacokinet; 1982; 7(4):363-72. PubMed ID: 7116738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
